Journal of Pharmaceutics & Drug Delivery Research ISSN: 2325-9604

Reach Us +1 209 730 0872
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, J Pharm Drug Deliv Res Vol: 5 Issue: 6

Quality by Design Based HPLC Method Development of Macitentan and its Related Compounds in Bulk Drugs

Lakshmi D, Hitesh Kumar P, Praveen M, Venkatesh S, Prakash Reddy TVS, Manish G and Jayachandran J*
Analytical Development Laboratory, Cipla Limited, Virgonagar, Bangalore, India
Corresponding author : Jeenet Jayachandran
Analytical Development Laboratory, Cipla Limited, Virgonagar, old madras road, Virgonagar, Bangalore, Karnataka-590043, India
Tel: +(91)-80-28472205/28471180
E-mail: [email protected]
Received: September 23, 2016 Accepted: November 10, 2016 Published: November 14, 2016
Citation: Lakshmi D, Hitesh Kumar P, Praveen M, Venkatesh S, Prakash Reddy TVS, et al. (2016) Quality by Design Based HPLC Method Development of Macitentan and Its Related Compounds in Bulk Drugs. J Pharm Drug Deliv Res 5:6. doi: 10.4172/2325-9604.1000158

Abstract

Macitentan is an oral medication, being used for the treatment of idiopathic pulmonary fibrosis. The present study describes the development of HPLC method and subsequent validation for the analysis of Macitentan, an active pharmaceutical ingredient (API) using a quality by design approach.Analysis of macitentan and its related substances was very interesting and challenging due to co-elution of critical pair 1 (impurity C and unknown impurity) and critical pair 2 (impurity D and macitentan). Objective of this study was to develop a robust high performance liquid chromatographic method for the separation of critical pair 1 and 2. An attempt was made to develop HPLC method using QbD principles. A qualityby-design (QbD) based method development can potentially lead to a more rugged method. The optimized HPLC method details: buffer consisting of sodium perchlorate (pH adjusted to 2.0 using perchloric acid) as mobile phase A and acetonitrile-buffer (8:2) v/v as mobile phase B using the column Purosphere RP 18e 100 mm × 4.6 mm ID, 3.0 µm(Make: Merck) maintained at 45 ºC with a flow rate of 1.0 mL/min in a gradient mode of elution and the UV detection was set as 220 nm.

Keywords: Pulmonary arterial hypertension; QbD, RP-HPLC; Design of experiments (DOE); Macitentan

Track Your Manuscript

Share This Page